WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :
Dr. Muhammad Baqir MR Fakhrildin
Download Article: Click Here

Search

Track Your Article

Abstract

ANGIOTENSIN RECEPTOR BLOCKER

Rekha Olivia* and Yulistiani

ABSTRACT

Angiotensin II receptor blockers (ARBs) represent a new class of antihypertensive drugs. The mechanism of action of ARB differs from angiotensin-converting (ACE) enzyme inhibitors, which also affect the renin-angiotensin system. The eight ARBs as antihypertensive approved by the FDA were candasartan, telmisartan, valsartan, losartan, irbesartan, eprosartan, olmesartan, azilsartan, while the ninth ARBs approved by the Korea Food and Drug Administration was fimasartan. ARB has a clinical profile that is very similar but it has a different pharmacokinetic profile.

Keywords: Angiotensin II receptor blockers different pharmacokinetic profile.


[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More